These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7774989)

  • 1. Effect of gemfibrozil versus lovastatin on increased serum lipoprotein(a) levels of patients with hypercholesterolemia.
    Ramires JA; Mansur AP; Solimene MC; Maranhão R; Chamone D; da Luz P; Pileggi F
    Int J Cardiol; 1995 Feb; 48(2):115-20. PubMed ID: 7774989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study Group.
    Sweany AE; Shapiro DR; Tate AC; Goldberg RB; Stein EA
    Clin Ther; 1995; 17(2):186-203. PubMed ID: 7614520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus.
    Goldberg R; La Belle P; Zupkis R; Ronca P
    Am J Cardiol; 1990 Sep; 66(8):16B-21B. PubMed ID: 2206032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels.
    McKenney JM; Barnett MD; Wright JT; Proctor JP
    Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gemfibrozil reduces elevated lipoprotein (a) levels in hypercholesterolemic patients].
    Ramires JA; Spósito AC; Mansur AP; Solimene MC; Chamone D; da Luz PL; Pileggi F
    Arq Bras Cardiol; 1997 Apr; 68(4):257-60. PubMed ID: 9497506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A crossover comparison of the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemic organ transplant recipients.
    Hanes DS; Nicholson PG; Raval DD; Hooper FL; Behrens MT; Weir MR
    Am J Ther; 1997; 4(2-3):85-91. PubMed ID: 10423597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
    Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.
    Vázquez M; Zambón D; Hernández Y; Adzet T; Merlos M; Ros E; Laguna JC
    Br J Clin Pharmacol; 1998 Mar; 45(3):265-9. PubMed ID: 9517370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia.
    Bredie SJ; Westerveld HT; Knipscheer HC; de Bruin TW; Kastelein JJ; Stalenhoef AF
    Neth J Med; 1996 Aug; 49(2):59-67. PubMed ID: 8824106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipoproteinemia.
    Vega GL; Grundy SM
    Arch Intern Med; 1994 Jan; 154(1):73-82. PubMed ID: 8267492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of lovastatin and gemfibrozil in normolipidemic patients with hypoalphalipoproteinemia.
    Vega GL; Grundy SM
    JAMA; 1989 Dec; 262(22):3148-53. PubMed ID: 2810673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.
    Simo IE; Yakichuk JA; Ooi TC
    Atherosclerosis; 1993 Apr; 100(1):55-64. PubMed ID: 8318063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary hypertriglyceridemia with borderline high cholesterol and elevated apolipoprotein B concentrations. Comparison of gemfibrozil vs lovastatin therapy.
    Vega GL; Grundy SM
    JAMA; 1990 Dec; 264(21):2759-63. PubMed ID: 2232062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of combined hyperlipidemia with lovastatin versus gemfibrozil: a comparison study.
    Ojala JP; Helve E; Tikkanen MJ
    Cardiology; 1990; 77 Suppl 4():39-49. PubMed ID: 2073671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of lipoprotein profile in familial dysbetalipoproteinemia with gemfibrozil.
    Zhao SP; Smelt AH; Leuven JA; Vroom TF; van der Laarse A; van 't Hooft FM
    Am J Med; 1994 Jan; 96(1):49-56. PubMed ID: 8304363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
    Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.
    Kerzner B; Corbelli J; Sharp S; Lipka LJ; Melani L; LeBeaut A; Suresh R; Mukhopadhyay P; Veltri EP;
    Am J Cardiol; 2003 Feb; 91(4):418-24. PubMed ID: 12586255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ; Lamon-Fava S; Cole T; Sprecher DL; Cilla DD; Balagtas CC; Rowan JP; Black DM
    Atherosclerosis; 1996 Nov; 127(1):113-22. PubMed ID: 9006811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.
    Zambón D; Ros E; Rodriguez-Villar C; Laguna JC; Vázquez M; Sanllehy C; Casals E; Sol JM; Hernández G
    Metabolism; 1999 Jan; 48(1):47-54. PubMed ID: 9920144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.